ALTISPIR Trademark

Trademark Overview

On Thursday, October 20, 2011, a trademark application was filed for ALTISPIR with the United States Patent and Trademark Office. The USPTO has given the ALTISPIR trademark a serial number of 85452415. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 29, 2015. This trademark is owned by Glaxo Group Limited. The ALTISPIR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the prevention, treatment, and/or alleviation of respiratory diseases and disorders
altispir

General Information

Serial Number85452415
Word MarkALTISPIR
Filing DateThursday, October 20, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 29, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 3, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the prevention, treatment, and/or alleviation of respiratory diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 25, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, June 29, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, June 29, 2015ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 23, 2014ASSIGNED TO EXAMINER
Tuesday, September 9, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 8, 2014EXTENSION 5 GRANTED
Friday, August 22, 2014EXTENSION 5 FILED
Friday, August 22, 2014TEAS EXTENSION RECEIVED
Wednesday, April 16, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 15, 2014EXTENSION 4 GRANTED
Thursday, April 10, 2014EXTENSION 4 FILED
Thursday, April 10, 2014TEAS EXTENSION RECEIVED
Wednesday, November 6, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 5, 2013EXTENSION 3 GRANTED
Thursday, October 24, 2013EXTENSION 3 FILED
Thursday, October 24, 2013TEAS EXTENSION RECEIVED
Friday, May 31, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 30, 2013EXTENSION 2 GRANTED
Monday, April 29, 2013EXTENSION 2 FILED
Friday, May 24, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 29, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, November 2, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 31, 2012EXTENSION 1 GRANTED
Wednesday, October 31, 2012EXTENSION 1 FILED
Wednesday, October 31, 2012TEAS EXTENSION RECEIVED
Tuesday, May 29, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 3, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 3, 2012PUBLISHED FOR OPPOSITION
Wednesday, March 14, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 9, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 7, 2012ASSIGNED TO EXAMINER
Tuesday, October 25, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, October 24, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

altispir respiratory diseases disorders alleviation treatment preparations substances prevention pharmaceutical